References
- Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C., FAB cooperative group. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982; 51: 189–192
- Mufti G., Stevens J., Oscier D., Hamblin T., Machin D. Myelodysplastic syndromes: A scoring system with prognostic significance. Br. J. Haematol. 1985; 59: 425–433
- Economopoulos T., Stathakis N., Foudoulakis A., et al. Myelodysplastic syndromes: analysis of 131 cases according to the FAB classification. Eur. J. Haematol. 1987; 38: 338–344
- Sanz G., Sanz M., Vallespi T., Canizo M., Torrabadella M., Garcia S., Irriguible D., San Miguel J. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: A multivariate analysis of prognostic factors in 370 patients. Blood 1989; 74: 395–408
- Kerkhofs H., Hermans J., Haak H. L., Leeksma C. H. W. Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br. J. Haematol. 1987; 65: 73–81
- Coiffier B., Adeleine P., Gentilhomme O., Felman P., Treille-Ritouet D., Bryon P. Myelodysplastic syndromes. A multiparametric study of prognostic factors in 336 patients. Cancer 1987; 60: 3029–3032
- Garcia S., Sanz M., Amigo V., Colomina P., Carrera M., Lorenzo J., Sanz G. Prognostic factors in chronic myelodysplastic syndromes: a multivariate analysis in 107 cases. Am. J. Haematol. 1988; 27: 163–169
- Raymakers R., De Witte T., Joziasse J., Van Der Lely N., Boezeman J., Haanen C. In vitro growth pattern and differentiation predict for progression of myelodysplastic syndromes to acute nonlymphocytic leukemia. Br. J. Haematol. 1991; 78: 35–41
- Yunis J. J., Rydell R. E., Oken M. M., Arnesen M. A., Mayer M. G., Lobell M. Refined chromosomal analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 1986; 67: 1721–1730
- Lidbeck J. In vitro colony and cluster growth in hemopoietic dysplasia (The preleukemic syndrome). II. Identification of a maturation defect in agar cultures. Stand. J. Haematol. 1980; 25: 113–123
- Rosenthal D., Moloney W. Refractory dysmyelo-poietic anaemia and acute leukemia. Blood 1984; 63: 314–318
- Oscier D., Worsley A., Darlow S., Figes A., Williams J., Hamblin T. Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score. Leuk. Res. 1989; 13: 833–839
- Schipperus M., Hagemeijer A., Ploemacher R., Lindemans J., Voerman J., Abels J. In myelodysplastic syndromes progression to leukemia is directly related to PHA dependency for colony formation and independent for in vitro maturation capacity. Leukemia 1988; 2: 433–437
- Schattenberg A., De Witte T., Salden M., Vet J., Van Dijk B., Smeets D., Hoogenhout J., Haanen C. Mixed Hematopoietic chimerism after allogeneic bone marrow transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse. Blood 1989; 73: 1367–1372
- De Witte T., Koekman E., Plas A., Blankenborg G., Salden M., Wessels J., Haanen C. Enrichment of myeloid clonogenic cells by isopyenic density equilibrium centrifugation in percoll gradients and counterflow centrifu-gation. Stem Cells 1982; 2: 308–320
- Moore M. A. S., Spitzer G., Williams N. Agar culture studies in 127 cases of untreated acute leukemia; the prognostic value according to in vitro growth characteristics. Blood 1974; 44: 1–18
- Baines P. Drying and staining soft agar cultures of hemopoietic colonies. Int. J. Cell Clon. 1989; 7: 136–137
- Matthews D. E., Farewell V. T. Using and Understanding Medical Statistics 2nd revised edn. Karger, Basel 1988, chapter VII
- Sanz G. F., Sanz A. M. Prognostic factors in myelodysplastic syndromes. Leuk. Res. 1992; 16: 77–86
- De Witte T., Gratwohl A. Bone marrow transplantation for myelodysplastic syndrome and secondary leukemias. Br. J. Haematol. 1990; 75: 442–445